# Congressional stock trades in EMN (Eastman Chemical Company)

Congressional stock trades in Eastman Chemical Company (EMN) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

- Industry: Plastic Materials, Synth Resins & Nonvulcan Elastomers
- Last close: $65.69
- Price updated: Sep 21, 2026
- Total congressional trades: 3
- Politicians trading: 2
- Last traded: Aug 4, 2025
- Source: https://tryglasshouse.ai/companies/EMN.md

## Trading History

- Page: 1 of 1
- Results: 3 of 3
- Pagination query parameter: `page`

## 1. Lisa C. McClain

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Aug 4, 2025, disclosed Sep 12, 2025
- Market context: $60.78 at trade, $65.69 current (+8.08%)
- Politician: https://tryglasshouse.ai/politicians/M001136.md
- Record: https://tryglasshouse.ai/trades/bb615042-acfd-4ac9-8508-f4b7578652aa.md

## 2. Lisa C. McClain

- Member: Republican, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Jun 17, 2025, disclosed Aug 13, 2025
- Market context: $75.17 at trade, $65.69 current (-12.61%)
- Politician: https://tryglasshouse.ai/politicians/M001136.md
- Record: https://tryglasshouse.ai/trades/ae806640-f8a4-49f8-9633-9ca5082d7a99.md

## 3. Robert Bresnahan

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded May 15, 2025, disclosed Jun 9, 2025
- Market context: $81.25 at trade, $65.69 current (-19.15%)
- Politician: https://tryglasshouse.ai/politicians/B001327.md
- Record: https://tryglasshouse.ai/trades/0506edac-7fd2-4537-b987-afd0dc7da9fc.md



## About Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.